Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
Open-label randomized controlled trial to study the efficacy of continuous daily use of
ethinylestradiol/levonorgestrel (30/150 µg/day) compared with vitamin E (400 IU/day) in the
treatment of women with menstrually-related and perimenopausal migraine.
Phase:
Phase 3
Details
Lead Sponsor:
Leiden University Medical Center
Collaborators:
Erasmus Medical Center Hersenstichting Netherlands Brain Foundation ZonMw: The Netherlands Organisation for Health Research and Development